Get started
Author

Michelle Niewood

Observed name: M. Niewood
OpenAlex ID: A5055426200
Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC).
2014 · Edward B. Garon, Natasha B. Leighl, et al. · Journal of Clinical Oncology · 64
Safety and clinical activity of MK-3475 as initial therapy in patients with advanced non-small cell lung cancer (NSCLC).
2014 · Naiyer A. Rizvi, Edward B. Garon, et al. · Journal of Clinical Oncology · 63
Abstract CT105: MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression
2014 · Leena Gandhi, Ani Balmanoukian, et al. · Cancer Research · 55
Abstract CT177: Epacadostat plus durvalumab in patients with advanced solid tumors: preliminary results of the ongoing, open-label, phase I/II ECHO-203 study
2018 · Aung Naing, John D. Powderly, et al. · Cancer Research · 26
Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2014 · A.S. Balmanoukian, N.A. Rizvi, et al. · International Journal of Radiation Oncology*Biology*Physics · 21
PDF
KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab.
2015 · Steven Francis Powell, Stephen V. Liu, et al. · Journal of Clinical Oncology · 11
412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors
2020 · Elena Garralda, Ravit Geva, et al. · Regular and Young Investigator Award Abstracts · 9
PDF
MO24-1 Phase I/IIa trial evaluating safety and clinical activity of DuoBody®-PD-L1×4-1BB (GEN1046) in advanced solid tumors
2021 · Ignacio Melero, Ravit Geva, et al. · Annals of Oncology · 5
PDF
Clinical Research in Pharmaceutical Drug Development
2021 · Srinivas Ghatta, Michelle Niewood · Drug Discovery and Development
Works count: 9
Citation count: 254
H-index: 7
I10-index: 6
Year
Topic
Type